Letrozole
Product Images NDC 24535-0801

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Letrozole (NDC 24535-0801). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Arab Pharmaceutical Manufacturing Co. Psc Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Structural Formula (Letrozole Tablets 01)

Structural Formula (Letrozole Tablets 01)
FDA Label Image

Figure 1 Disease-free Survival (median Follow-up 73 Months, Itt Approach) (Letrozole Tablets 02)

Figure 1 Disease-free Survival (median Follow-up 73 Months, Itt Approach) (Letrozole Tablets 02)
FDA Label Image

Figure 2 Kaplan-meier Estimates Of Time To Progression (tamoxifen Study) (Letrozole Tablets 03)

Figure 2 Kaplan-meier Estimates Of Time To Progression (tamoxifen Study) (Letrozole Tablets 03)
FDA Label Image

Figure 3 Survival By Randomized Treatment Arm (Letrozole Tablets 04)

Figure 3 Survival By Randomized Treatment Arm (Letrozole Tablets 04)
FDA Label Image

Figure 4 Kaplan-meier Estimates Of Time To Progression (megestrol Acetate Study) (Letrozole Tablets 05)

Figure 4 Kaplan-meier Estimates Of Time To Progression (megestrol Acetate Study) (Letrozole Tablets 05)
FDA Label Image

Figure 5 Kaplan-meier Estimates Of Time To Progression (aminoglutethimide Study) (Letrozole Tablets 06)

Figure 5 Kaplan-meier Estimates Of Time To Progression (aminoglutethimide Study) (Letrozole Tablets 06)
Letrozole is a medication available in tablet form with a strength of 0.5 mg. No additional information is available from the provided text.*
FDA Label Image

Ndc 24535-0801-1letrozole Tablets, Usp2.5 mgrx Only30 Tablets (Letrozole Tablets 07)

Ndc 24535-0801-1letrozole Tablets, Usp2.5 mgrx Only30 Tablets (Letrozole Tablets 07)
This is a description of a medication containing 25 mg of letozok. The text includes some unclear characters and codes, but it also indicates the name and address of the manufacturer or distributor of the medication.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.